Predictive factors for response to peginterferon-alpha and ribavirin treatment of chronic HCV infection in patients aged 65 years and more

Digestive Diseases and Sciences

Volumn 55, Issue 11, 2010, Pages 3193-3199

  Giannini, Edoardo G ^a   Basso, Monica ^a   Savarino, Vincenzo ^a   Picciotto, Antonino ^a  

^a UNIVERSITY OF GENOA   (Italy)

Author keywords

Elderly; Hepatitis C virus; Pegylated interferon; Ribavirin; Sustained virological response

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; ERYTHROPOIETIN; PEGINTERFERON ALPHA2A; PEGINTERFERON ALPHA2B; RIBAVIRIN; VIRUS RNA;

AGE; AGED; ANEMIA; ANGINA PECTORIS; ANTIVIRAL THERAPY; ARTHRALGIA; ARTICLE; ASTHENIA; BILIRUBIN BLOOD LEVEL; BODY MASS; DRUG DOSE REDUCTION; FEMALE; GENOTYPE; HEART FAILURE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INFLUENZA; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; NAUSEA AND VOMITING; PREDICTION; PREMEDICATION; PRIORITY JOURNAL; RETINOPATHY; THROMBOCYTE COUNT; TREATMENT WITHDRAWAL; VIRUS CHARACTERIZATION; VIRUS LOAD; VOMITING;

AGED; ANTIVIRAL AGENTS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTENTION TO TREAT ANALYSIS; INTERFERON ALFA-2A; INTERFERON ALFA-2B; MALE; POLYETHYLENE GLYCOLS; PROSPECTIVE STUDIES; RIBAVIRIN; TREATMENT OUTCOME; VIRAL LOAD;

EID: 78149359709     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-010-1408-x     Document Type: Article

References (23)

1. MJ Alter 2007 Epidemiology of hepatitis C virus infection World J Gastroenterol 13 2436 2441 17552026
2. JI Esteban S Sauleda J Quer 2008 The changing epidemiology of hepatitis C virus infection in Europe J Hepatol 48 148 162 10.1016/j.jhep.2007.07.033 18022726 (Pubitemid 350191999)
3. GL Armstrong A Wasley EP Simard GM McQuillan, et al. 2006 The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 Ann Intern Med 144 705 714 16702586
4. GL Davis JE Albright SF Cook DM Rosenberg 2003 Projecting future complications of chronic hepatitis C in the United States Liver Transpl 9 331 338 10.1053/jlts.2003.50073 12682882 (Pubitemid 36443043)
5. C Mazzeo F Azzaroli S Giovanelli A Dormi, et al. 2003 Ten year incidence of HCV infection in northern Italy and frequency of spontaneous viral clearance Gut 52 1030 1034 1:STN:280:DC%2BD3s3psV2jug%3D%3D 10.1136/gut.52.7.1030 12801962 (Pubitemid 36765297)
6. D Thabut S Le Calvez V Thibault J Massard, et al. 2006 Hepatitis C in 6,865 patients 65 years or older: a severe and neglected curable disease? Am J Gastroenterol 101 1260 1267 10.1111/j.1572-0241.2006.00556.x 16771947 (Pubitemid 43829992)
7. LB Seeff JH Hoofnagle 2003 Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002 Clin Liver Dis 7 261 287 10.1016/S1089-3261(02)00078-8 12691470 (Pubitemid 36350763)
8. MP Manns JG McHutchinson SC Gordon VK Rustgi, et al. 2001 Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Lancet 358 958 965 1:CAS:528:DC%2BD3MXntF2qtb8%3D 10.1016/S0140-6736(01)06102-5 11583749 (Pubitemid 32913521)
9. MW Fried ML Shiffman KR Reddy C Smith, et al. 2002 Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection N Engl J Med 347 975 982 1:CAS:528:DC%2BD38Xnt12rtb0%3D 10.1056/NEJMoa020047 12324553
10. A Floreani E Minola I Carderi I Carderi, et al. 2006 Are elderly patients poor candidates for pegylated interferon plus ribavirin in the treatment of chronic hepatitis C? J Am Geriatr Soc 54 549 550 10.1111/j.1532-5415.2006.00643- 4.x 16551333 (Pubitemid 43327180)
11. CG Nudo P Wong N Hilzenrat M Deschênes 2006 Elderly patients are at greater risk of cytopenia during antiviral therapy for hepatitis C Can J Gastroenterol 20 589 592 1:STN:280:DC%2BD28rntVOjtQ%3D%3D 17001400
12. G Antonucci MA Longo C Angeletti F Vairo, et al. 2007 The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 year Am J Gastroenterol 102 1383 1391 1:CAS:528:DC%2BD2sXoslGlt7k%3D 10.1111/j.1572-0241. 2007.01201.x 17403072 (Pubitemid 46976284)
13. CF Huang JF Yang CY Dai JF Huang, et al. 2010 Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C J Infect Dis 201 705 709 10.1086/650470
14. S Chevaliez JM Pawlotsky 2007 Practical use of hepatitis C virus kinetics monitoring in the treament of chronic hepatitis C J Viral Hepat 14 Suppl. 1 77 81 10.1111/j.1365-2893.2007.00923.x 17958647 (Pubitemid 47628702)
15. K Ishak A Baptista L Bianchi F Callea, et al. 1995 Histological grading and staging of chronic hepatitis J Hepatol 22 696 699 1:STN:280: DyaK28%2FjsFWntw%3D%3D 10.1016/0168-8278(95)80226-6 7560864
16. P Bedossa T Poynard 1996 An algorithm for the grading of activity in chronic hepatitis C. The METAVIR cooperative study group Hepatology 24 289 293 1:STN:280:DyaK28zhvFClug%3D%3D 10.1002/hep.510240201 8690394
17. GL Davis 2002 Monitoring of viral levels during therapy of hepatitis C Hepatology 36 Suppl 1 S145 S151 10.1002/hep.1840360719 12407588
18. MJ Tong NS el-Farra AR Reikes RL Co 1995 Clinical outcomes after transfusion-associated hepatitis C N Engl J Med 332 1463 1466 1:STN:280:DyaK2M3lvVSqsQ%3D%3D 10.1056/NEJM199506013322202 7739682
19. F Monica F Lirussi G Nassuato MR Castelletto, et al. 1998 Hepatitis C virus infection and related chronic liver disease in a resident elderly population: the Silea study J Viral Hepat 5 345 351 1:STN:280: DyaK1M%2Fht1Sisw%3D%3D 10.1046/j.1365-2893.1998.00112.x 9795919 (Pubitemid 28440330)
20. M Sawabe T Arai Y Esaki T Fukazawa, et al. 1999 Persistent infection of hepatitis C virus in the elderly: a clinical an quantitative pathological study of autopsy cases Liver 19 335 342 1:STN:280:DyaK1Mzosleruw%3D%3D 10.1111/j.1478-3231.1999.tb00058.x 10459633 (Pubitemid 29359099)
21. T Honda Y Katano J Shimizu Y Ishizu, et al. 2010 Efficacy of peginterferon-α-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis C Liver Int 30 527 537 1:CAS:528:DC%2BC3cXkt1amurc%3D 10.1111/j.1478-3231.2009.02064.x 19523048
22. E Giannini F Botta S Caglieris A Fasoli, et al. 1999 Chronic liver disease related to hepatitis C virus: age of patients seems to be the main determinant of severity independently of viral genotype" Eur J Gastroenterol Hepatol 11 553 558 1:STN:280:DC%2BD3c3hs1SgtQ%3D%3D 10.1097/00042737-199905000-00015 10755261
23. A Floreani 2009 Hepatitis C: should antiviral therapy be offered to elderly patients? Nat Rev Gastroenterol Hepatol 6 503 504 1:CAS:528: DC%2BD1MXhtVKjsLzE 10.1038/nrgastro.2009.138 19713980